



844-3 Comparative Outcomes of Percutaneous Coronary  
Interventions in Diabetics Versus Nondiabetics With 
Prior Coronary Artery Bypass Graft ing 
Verahese Mathew. Stephanie Wilson, Gregory W. Barsness, Robert L. Frye, Ryan 
Lennon, David R. Holmes, Jr., Mayo Clinic and Foundation, Rochester, Minnesota. 
Background: Randomized data suggests that coronary artery bypass graft (CABG) is 
superior to percutaneous coronary intervention (PCI) as an initial revasculadzation strat- 
egy in diabetics with multi-vessel coronary disease, although these data excluded 
patients with prior CABG. 
Methods: Patients with prior CABG undergoing PCI from January 1, 1996 through 
August 31, 2000 were divided into two groups based on whether or not they had diabe- 
tes, excluding patients with acute infarction or shock. Cox proportional hazards models 
were utilized to estimate the association between diabetes and adverse events. 
Results: 1,153 post-CABG PCI patients were identified (326 diabetics and 827 non-dia- 
betics). Diabetics were younger, more likely to have hypertension, heart failure, and 
lower ejection fraction. Procedural characteristics and angiographic and procedural suc- 
cess rates were similar. 
Diabetes was associated with increased mortality (hazard ratio (HR) 1.58, 95 % confi- 
dence intervals (CI) 1.10 - 2.27). Diabetes did not have a significant effect on mortality in 
patients treated for single territory coronary disease (HR 1.44, 95 % CI 0.69 - 3.02), but 
did in patients with multi-territory disease (HR 1.79, 95% CI 1.16-2.76). However, in dia- 
betics with multi-territory disease who were completely revascularized with PCI, mortality 
was comparable to non-diabetics (HR 1.32, 95 % CI 0.57 - 3.03). 
Conclusion: Among PCI patients with prior CABG, diabetes portends an adverse progno- 
sis, although diabetics treated for single territory coronary disease or multiple territory 
disease undergoing complete percutaneous revascularization had comparable survival 
to non-diabetics. 
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angiographical restenosis and clinical outcome as compared to cutting balloon angio- 
plasty. These results suggest that cutting balloon angioplasty with provisional stanting 
might be a better option for treating lesions in small coronary vessels in diabetic patients. 
Cutting balloon Stent p value 
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844-4 Impact  of  Diabetes on Out-of -Hospi ta l  Surv ival  
Following Percutaneous Coronary Intervention: A Case- 
Control Study 
Sean R. Wilson, Babak A. Vakili, Warren Sherman, Kumar L. Ravi, Timothy A. Sanborn, 
David L. Brown, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, 
New York. 
Background: Based upon data derived prior to the availability of coronary stants, diabet- 
ics are thought to have impaired survival following percutaneous coronary intervention' 
(PCI) compared to non-diabetics. We sought to determine whether diabetics continue to 
have greater mortality than non-diabetics following PCI performed in the era of wide- 
spread availability of coronary stints. 
Methods: Three hospitals in New York City contributed prospectively defined data ele- 
ments on 4400 consecutive patients undergoing PCI. From this data set, 851 diabetics 
were identified and matched for age, gender and extent of coronary disease to 851 non- 
diabetics. Mortality rates at a mean follow-up of 2.4 years were compared using Kaplan- 
Meier and Cox proportional hazards models. 
Results: In both groups the mean age was 63.4 years, 38% of patients were females, 
43% had 1 -vessel coronary artery disease (CAD), 32% had 2-vessel CAD and 24% had 
3-vessel CAD. Diabetic patients had a greater incidence of hypertension (77% vs. 71%, 
P=0.002), congestive heart failure on admission (7.6% vs. 3.7%, P=0.001), renal insuffi- 
ciency (4.2% vs. 1.6%, P=0.0O2) and dialysis (3.4% vs. 1.3%, P=0.004). Prior myocardial 
infarction (MI) was noted in 35% of both groups. An MI within 24 hours of PCI was diag- 
nosed in 5.5% of diabetics and 6.5% of non-diabetics (P=NS). The mean ejection fraction 
of diabetics was 50% compared to 51% for non-diabetics (P=0.005). Stents were placed 
in 77% of diabetics and 79% of non-diabetics (P=NS). GP lib/Ilia inhibitors were adminis- 
tered to 24% of diabetics and non-diabetics. Procedural success was 97% in both 
groups. In-hospital mortality was 0.8% for diabetics and 0.2% for non-diabetics 
(P=0.095). At a mean follow-up of 2.4 years, the mortality rate for diabetics was 14.2% 
compared to 6.8% for non-diabetics (Hazard Ratio: 1.73, 95% Confidence Interval 1.22- 
2.44, P=0.002). 
Conclusion: Diabetic patients continue to experience increased mortality compared to 
non-diabetics following PCI. Additional studies are required to define the optimal treat- 
ment of CAD in these patients. 
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844-5 Compar i son  With Coronary  Stent  and Cut t ing  Balloon 
in Smel l  Coronary  Vessels  in Diabet ic  Pat ients  
Katsuhiro Kawaauchi, Taizo Kondo, Tomomichi Suzuki, Yoshio Kakegawa, Yoshifumi 
Awaji, Komaki City Hospital, Komaki City; Japan. 
Background: Diabetic patients have an increased incidence of cardiac events and rest- 
enosis compared with non-diabetic patients after pemutaneous coronary interventions. 
The efficacy of coronary intervention for small vessels in diabetic patients is unknown. 
Methods: We performed elective coronary angioplasty using cutting balloon (CB) in 51 
diabetic patients, and stint in 35 diabetic patients, with a reference vssse~ <2.6ram in 
diameter. Chronic total occlusions, in-stent restenosis, rotational atherectomy followed by 
stanting were excluded in this study. Results: Stent group patients were older than CB 
group patients (66.0 vs. 61.0 years; p<0.01), There were no significant differences in 
other baseline clinical characteristics between two groups. QCA analysis and restenosis 
rate are presented below, Conclusions: In spite of better initial angiographic results, 
stinting in small vessels in diabetic patients does not provide any benefit in terms of 
Ctinical success 80.7% 97.1% 0.02 
Reference diameter, mm 2.22±0.27 2.20±0.25 NS 
De novo lesion 73.7% 68.6% NS 
Lesion length, mm 10.01 ±4.50 11.98±4.93 NS 
Pre MLD, mm 0.71±0.18 0.63±0.21 0.04 
Post MLD, mm 1.72±0.36 2.27±0.28 <0.0001 
F/U MLD, mm 1.19±0.50 1.19±0.53 NS 
Restanosis rate 31.7% 40.7% NS 
MACE, TLR (<6month) 31.7% 38.2% NS 
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844-6 Abnormal Hemoglobin Alc  Is Assoc ia ted  With an 
Increased Rate of Target Vessel Revascularization in 
Nondlabet ic  Pat ients  Undergoing Percutaneous 
Coronary  Revaacular lzat ion 
Roberto A. Comus. Jr.. Judith A. Boura, Steven C. Ajluni, William H. Devlin, Simon R. 
Dixon, Gerald C. "rimmis, William W. O'Neill, William Beaumont Hospital, Royal Oak, 
Michigan. 
Background: Prior studies have demonstrated that abnormalities in plasma glucose 
below the "diabetic range' of glycemia are associated with increased cardiovascular mor- 
tality in nondiabetic (nonDM) patients (pts). We examined the association between glyce- 
mic control as determined by hemoglobin Arc (Alc) and incidence of target vessel 
revascularization (TVR) in nonDM undergoing elective percutaneous coronary interven- 
tion (PCI). 
Methods: Baseline laboratory studies including Alc were drawn in 438 consecutive pts 
prior to elective PCI. NonDM pts were defined as pts without a history of diet or pharma- 
cologically controlled diabetes and At c < 7.0. Pts were followed for 1 year after the index 
PCI. 
Results: Of the 438 pts enrolled, 292 (66%) were nonDM. An abnormal Alc was found 
in 39% of nonDM. NonDM with Alc > 6.0% were more often male, had higher triglycer- 
ides and prior history of MI compared to nonDM with Alc < 6.0%. NonDM with Alc > 
6.0% had a similar rate of TVR compared to diabetic pts (p=NS), but a significantly 







Conclusions: In nonDM pts undergoing PCI, the incidence of chronic hyperglycemia as 
determined by A lc> 6.0% is approximately 40%. Among nonDM, A lc> 6.0% is associ- 
ated with a significantly higher rate of TVR. These data suggest that screening for hyper- 
glycemia may be beneficial in pts undergoing PCI. Further studies are needed to 
determine if lifestyle modification and/or pharmacologic therapy would be beneficial in 
this high-risk population. 
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1148-1 Pulmonary Function Tests After Revascularization 
Gordon E. Pate. Michelle Agnew, Brandan Foley, Peter Craan, Finbarr O'Connell, 
Michael J. Walsh, Saint James's Hospital, Dublin, Ireland. 
Background: Percutaneous transiuminal coronary angioplasty (PTCA) and coronary 
artery bypass surgery (CABG) are almost equivalent in terms of symptom relief, compli- 
cations and mortality. The importance of non-cardiac effects of revascularisation, such as 
neuro-cognitive decline,is increasingly being recognized. 
Methods: This study examined the effects of PTCA on PFTs in 33 patients at six weeks 
and again at six months. This was compared with PFTs in 33 patients before and six 
months after CABG. 
Results: At six months after PTCA there was a drop in FEV1/FVC ratio from 78% to 76% 
(p<0.02) compared to baseline, due to a small increase in FVC (forced vital capacity) 
which was statistically significant at 6 weeks (+5%, p<0.03) but not at 6 months (+3%, 
p=0.23). There was a drop in FEF25-75% (-8%, p<0.05). There had been no significant 
changes in FEVl/FVC or FEF25-75% at six weeks. At neither six weeks nor at six 
months were there any statistically significant changes in FEVt (forced expiratory vol- 
